Those who invested in Pfizer three years ago and hung on are not thrilled. They would have done much better with a simple S&P ...

Downtown Harrisonville's charm sat dormant behind empty storefronts, padlocked front doors, and boarded-up windows.

Pfizer: The drugmaker has launched its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) in India for adult immunisation against 20 serotypes responsible for most invasive and ...

Valneva confirmed its outlook for 2025, including expectations for total revenue between 180 million and 190 million euros. Total revenue last year was approximately 170 million euros. With Pfizer, ...

Eli Lilly and Co. has already launched LillyDirect service, which CEO David Ricks says jibes with the administration’s demand ...

Indian benchmarks indices, the BSE Sensex and NSE Nifty, are set to open in positive terrain on Tuesday, taking firm cues ...

Pfizer's second-quarter results were better than expected. The drugmaker will still face some near-term uncertainty. However, its long-term prospects look attractive, especially at current levels. 10 ...

Pfizer Inc. (NYSE:PFE) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Pfizer Inc. (NYSE:PFE) reported ...

The new targeted pipeline will advance Nxera’s oral GLP-1 agonists, novel GPCR targets, and structure-based drug design to ...

Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...

Counterfeit Medicine is a growing global threat. At Pfizer, a dedicated team is leading the fight to stop these dangerous ...

Discover key insights from Roivant Sciences' Q1 2025 earnings call, including brepocitinib DM data milestones, financial strength, and strategic ...